PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial) — Stella

Recruiting

Back to Neuroendocrine Neoplasia's (NENs) trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

India

Tata Memorial Hospital, Mumbai, India, Mumbai, Maharashtra

Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai, Maharashtra

Key details

Phase

Large-scale testing

Sponsor

Tata Memorial Hospital

Enrollment target

~162 participants

Started

August 2019

Primary completion

August 2027

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov